Dr. Douglas Piernick, MD
20030 Mack Ave, Grosse Pointe Woods, MI 48236 • +1-706-555-7950
Medical Education: Accredited U.S. Medical School (Class of 1993)
What This Doctor Actually Performs: CMS Medicare Utilization & Grosse Pointe Woods Percentiles
NPI #1487053575 • CBSA Regional • Dermatology
Operating out of Grosse Pointe Woods, MI (20030 Mack Ave), Dermatology clinician Dr. Douglas Piernick, MD (accredited MD/DO training, 1993) maintains a upper-quartile active clinical volume (75th Grosse Pointe Woods percentile) (84.53th MI percentile; Z-score +0.56σ across 5,428 documented services) with sub-specialty concentration in 86 Active CMS HCPCS Codes.
Granular CPT/HCPCS billing distribution at 20030 Mack Ave shows Dr. Douglas Piernick's primary concentration in Cryotherapy Destruction of Premalignant Actinic Lesion (code 17000: 1775x/yr, 75th local percentile) alongside Focused Cutaneous & Dermoscopic Examination (99213: 1618x/yr, $149–$204).
Self-pay new patient consultations with Dr. Piernick (CPT 99204 GPCI-adjusted benchmark) estimate around $209.00 (community reported average: $209.00) with hybrid in-clinic and telehealth video consults, 14-minute average reception wait, and a 4.49/5 modern protocol openness score across 10 patient logs.
Spanning 33 years of clinical practice following 1993 graduation from medical training, Dr. Douglas Piernick integrates 86 Active CMS HCPCS Codes diagnostics for Grosse Pointe Woods metro patients.
Compared against Grosse Pointe Woods, MI Dermatology peers
5,428 annual services across 899 beneficiaries
Standard deviations from MI Dermatology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 17000 | Cryotherapy Destruction of Premalignant Actinic Lesion | 1,775 | 75th | $133 – $183 |
| 99213 | Focused Cutaneous & Dermoscopic Examination | 1,618 | 79th | $149 – $204 |
| 11102 | Tangential Diagnostic Skin Biopsy of Single Lesion | 992 | 70th | $196 – $269 |
| 11401 | Excision of Benign Cutaneous Lesion (0.6 to 1.0 cm) | 522 | 73th | $275 – $377 |
| 99203 | New Patient Full-Body Skin Cancer & Dermatology Evaluation | 313 | 73th | $212 – $291 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (86 HCPCS billing breadth) | 208 | 75th | $163 – $236 |
Are you Dr. Douglas Piernick? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Grosse Pointe Woods, MI:
<a href="https://dotmd.com/doctors/douglas-piernick-md-grosse-pointe-woods-mi-1487053575" title="Dr. Douglas Piernick, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1487053575.svg" alt="Dr. Douglas Piernick Dermatology Badge" width="280" height="72" /></a>
Dr. Douglas Piernick, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Piernick National Provider Identifier | NPI #1487053575 (MD) | CMS NPPES Registry (48236) |
| Dr. Piernick Grosse Pointe Woods CMS Volume Rank | 75.00th Pct (5,428 CMS svcs; Z +0.560σ) | CMS Medicare Part B (MI Dermatology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Grosse Pointe Woods, MI) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 14 min lobby wait | 10 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.67/5 Listening • 4.49/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Douglas Piernick
Other High-Volume Dermatology Specialists in Grosse Pointe Woods, MI
Ranked strictly by CMS Medicare volumeDr. Piernick Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Grosse Pointe Woods, MI.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Douglas Piernick community threads and patient logs by age, biological sex, dosage, and treatment duration.